AP1S3A
| Species | Cat.# | Product name | Source (Host) | Tag | Protein Length | Price |
|---|---|---|---|---|---|---|
| Zebrafish | AP1S3A-2476Z | Recombinant Zebrafish AP1S3A | Mammalian Cell | His |
|
- Involved Pathway
- Protein Function
- Interacting Protein
AP1S3A involved in several pathways and played different roles in them. We selected most pathways AP1S3A participated on our site, such as Adaptive Immune System, Clathrin derived vesicle budding, Golgi Associated Vesicle Biogenesis, which may be useful for your reference. Also, other proteins which involved in the same pathway with AP1S3A were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
| Pathway Name | Pathway Related Protein |
|---|---|
| Adaptive Immune System | VPRBP;GM11711;CXADR;Siglece;CD226;CD300LB;CTSC;MOV10;UFL1 |
| Clathrin derived vesicle budding | ARF1;CPD;CNO;BLOC1S1;AP1S3A;AP1B1;SNX9B;TCEAL4;PLDN |
| Golgi Associated Vesicle Biogenesis | PUM1;PICALMA;PICALMB;AP1S3A;PPIAL4A;AP3S1;BLOC1S4;FTH1A;HIP1R |
| Immune System | SPSB4;TAX1BP1;DZIP3;ABI1A;BFB;DEFA6;ABI1B;ASB18;UBE2J2 |
| Lysosome Vesicle Biogenesis | BLOC1S1;CLVS1;DNASE2;AP4B1;AP1S3A;CLVS2;CTSZ |
| MHC class II antigen presentation | KIF3C;CTSH;IFI30;CTSLL;DYNC1LI2;DCTN6;KIFAP3;ACTR1B;MGC174155 |
| Membrane Trafficking | SEC16B;LMAN2;EXOC3;BET1;CX30.3;GJC1;ANKRD28;NSFA;FTH1A |
| Vesicle-mediated transport | HYOU1;NAPG;FTH1A;CD163;BLOC1S6;DTNBP1B;PPP6R1;TRAPPC10;DNASE2 |
AP1S3A has several biochemical functions, for example, protein transporter activity. Some of the functions are cooperated with other proteins, some of the functions could acted by AP1S3A itself. We selected most functions AP1S3A had, and list some proteins which have the same functions with AP1S3A. You can find most of the proteins on our site.
| Function | Related Protein |
|---|---|
| protein transporter activity | AP3S1;VPS26B;RANGRF;SEC62;AP4S1;CCT6B;RAMP2;XPO5;SOSTDC1B |
AP1S3A has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with AP1S3A here. Most of them are supplied by our site. Hope this information will be useful for your research of AP1S3A.
- Q&As
- Reviews
Q&As (20)
Ask a questionThe AP1S3A is involved in endocytosis and endocrine transport.
The study of AP1S3A is helpful to understand the molecular mechanism of endocytosis and endocrine processes, and has important significance for the treatment of related diseases.
In the absence of AP1S3A , endocytosis and endocrine transport processes may be affected, resulting in abnormal cell function.
At present, it has not been found that AP1S3A has a direct association with tumor, but its role in the development of tumor can be further studied.
The molecular mechanism of AP1S3A is still unclear, and further studies are needed to further understand its mechanism of action.
The AP1S3A may interact with other subunits in the AP1 complex, and the specific interactions need to be further studied.
The study of AP1S3A is faced with technical challenges and resource constraints, such as peptide synthesis, efficient expression of , and difficulty in clinical trials.
The research of AP1S3A is still in its infancy, and more experiments and studies are needed to further understand its function and application.
The AP1S3A can be studied as a potential drug target to explore its potential application in disease treatment.
The pharmacokinetic properties of AP1S3A are still unclear and need further study.
At present, the AP1S3A may be associated with some immune-related diseases, but the specific disease mechanism needs to be further studied.
The bioactivity of AP1S3A can be evaluated through a series of cellular and in vivo experiments, including the detection of its effect on cell function and its effect in animal models.
The synthetic methods of AP1S3A include chemical synthesis and genetic engineering technology. In general, the synthetic method using recombinant DNA technology is the most common method.
The AP1S3A is a polypeptide chain, and its specific structural characteristics may need to be studied by experimental techniques.
The expression of the AP1S3A can be artificially synthesized using recombinant DNA technology and then expressed through eukaryotic or prokaryotic expression systems.
At present, there is no specific antibody of AP1S3A available for use, and further research is needed.
Preclinical studies of AP1S3A are currently limited, and more experiments and validation are needed to further understand its potential applications.
The stability of AP1S3A may be affected by its expression mode and the environment in which it is used, and needs to be evaluated according to specific study conditions.
The therapeutic potential of AP1S3A is unclear, and more clinical trials are needed to evaluate its effectiveness in treating specific diseases.
AP1S3A has no clear clinical application at present, but it may have more research value in the scientific research field.
Customer Reviews (3)
Write a reviewAP1S3A is very safe and can be used with confidence.
Experiments with AP1S3A were very reproducible and allowed me to evaluate the results more accurately.
The band clarity of AP1S3A in Western blot is very high, which improves the reliability of the experiment.
Ask a Question for All AP1S3A Products
Required fields are marked with *
My Review for All AP1S3A Products
Required fields are marked with *
